DEVELOPMENT OF A COMPREHENSIVE PATIENT MANAGEMENT SYSTEM

综合患者管理系统（CPMS）旨在通过加强患者评估来管理信息和改善健康结果。CPMS系统地捕捉患者在初始、退出和复诊时对症状、社会心理变量、生活质量（QOL）和治疗反应的直接输入。在第一阶段，开发了一个原型，用于分析症状模式，并生成面向问题的健康摘要，供医生审查和编辑作为临床报告。患者对CPMS的接受程度在整个计算机体验范围内都很热情。医生们发现这份报告准确而有用。在第二阶段，该系统将重新设计用于商业应用。临床应用将改进为一般医疗评估，质量管理和患者满意度。CPMS将在临床环境中进行内部测试和beta测试。目标仍然不是做出诊断，而是有效地收集和管理患者数据，从而促进护理和支持医患沟通。对病人的价值是更多地参与他们的护理。对医疗保健提供者的价值在于提高效率、更全面的评估以及自我监控和改善结果的机会。对研究组织的价值是在实践环境中进行严格结果试验的工具。建议的商业应用：该软件系统旨在增强和捕获患者评估，生活质量（QOL）测量和医生流程。一旦确立了可行性，商业价值将源于在对照试验中作为结果工具，以及在实践中作为一种提高和衡量患者结果的机制。

Comprehensive Patient Management Systems (CPMS) is designed to manage information and improve health outcomes by enhancing patient assessment. CPMS systematically captures direct patient input at initial, exit and revisit sessions on symptoms, psychosocial variables, quality of life (QOL) and treatment response. In Phase I, a prototype was developed that analyzed symptom patterns and generated a problem-oriented health summary for physician review and editing as a clinical report. Patient acceptance of CPMS was enthusiastic across the full range of computer experience. Physicians found the report accurate and useful. In Phase II, the system will be re-engineered for commercial application. Clinical applications will be refined for a general medical assessment, quality management and patient satisfaction. CPMS will undergo internal testing and beta-testing in clinic settings. The goal remains not to make diagnoses, but to efficiently collect and manage patient data thereby facilitating care and supporting patient-physician communication. The value to patients is greater involvement in their care. The value to healthcare providers is increased efficiency, more comprehensive assessment and the opportunity to self-monitor and improve outcomes. The value to research organizations is a tool for rigorous outcome trials in practice settings. PROPOSED COMMERCIAL APPLICATIONS: This software system is designed to enhance and capture patient assessment, quality of life (QOL) measurement, and physician process. Once feasibility has been established, commercial value will stem from use as an outcome tool in controlled trials and as a mechanism to enhance and measure patient outcomes in practice settings.